Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Nitta

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Shigaku = Odontology; Journal of Nihon Dental College|June 1, 1983
[A case of surgical correction using both the Wassmund-Wunderer method and step-ostectomy for mandibular mobilization in open bite]Y Kumaxawa, I Nitta, K Mashiko, et al.
The Japanese Journal of Antibiotics|December 1, 1993
[Clinical pharmacology and efficacy of S-1108]N Aoki, Y Usuda, Y Koda, et al.
Journal of Medicinal Chemistry|January 1, 1991
A new class of HIV-1-specific 6-substituted acyclouridine derivatives: synthesis and anti-HIV-1 activity of 5- or 6-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT)H Tanaka, M Baba, H Hayakawa, et al.
Shigaku = Odontology; Journal of Nihon Dental College|October 1, 1982
[Clinical evaluation of a dry socket dressing for postextraction pain]I Nitta, M Saotome, Y Niijima, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1990
Anti-human immunodeficiency virus type 1 activities and pharmacokinetics of novel 6-substituted acyclouridine derivativesM Baba, E De Clercq, S Iida, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1991
Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptaseM Baba, E De Clercq, H Tanaka, et al.
Journal of Medicinal Chemistry|April 1, 1991
Specific anti-HIV-1 "acyclonucleosides" which cannot be phosphorylated: synthesis of some deoxy analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymineH Tanaka, M Baba, S Saito, et al.
Journal of Medicinal Chemistry|January 24, 1992
Structure-activity relationships of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine analogues: effect of substitutions at the C-6 phenyl ring and at the C-5 position on anti-HIV-1 activityH Tanaka, H Takashima, M Ubasawa, et al.
Molecular Pharmacology|June 1, 1991
Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivativesM Baba, E De Clercq, H Tanaka, et al.
Journal of Medicinal Chemistry|December 11, 1992
Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agentsH Tanaka, H Takashima, M Ubasawa, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Shigaku = Odontology; Journal of Nihon Dental College|June 1, 1983
[A case of surgical correction using both the Wassmund-Wunderer method and step-ostectomy for mandibular mobilization in open bite]Y Kumaxawa, I Nitta, K Mashiko, et al.
The Japanese Journal of Antibiotics|December 1, 1993
[Clinical pharmacology and efficacy of S-1108]N Aoki, Y Usuda, Y Koda, et al.
Journal of Medicinal Chemistry|January 1, 1991
A new class of HIV-1-specific 6-substituted acyclouridine derivatives: synthesis and anti-HIV-1 activity of 5- or 6-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT)H Tanaka, M Baba, H Hayakawa, et al.
Shigaku = Odontology; Journal of Nihon Dental College|October 1, 1982
[Clinical evaluation of a dry socket dressing for postextraction pain]I Nitta, M Saotome, Y Niijima, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1990
Anti-human immunodeficiency virus type 1 activities and pharmacokinetics of novel 6-substituted acyclouridine derivativesM Baba, E De Clercq, S Iida, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1991
Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptaseM Baba, E De Clercq, H Tanaka, et al.
Journal of Medicinal Chemistry|April 1, 1991
Specific anti-HIV-1 "acyclonucleosides" which cannot be phosphorylated: synthesis of some deoxy analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymineH Tanaka, M Baba, S Saito, et al.
Journal of Medicinal Chemistry|January 24, 1992
Structure-activity relationships of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine analogues: effect of substitutions at the C-6 phenyl ring and at the C-5 position on anti-HIV-1 activityH Tanaka, H Takashima, M Ubasawa, et al.
Molecular Pharmacology|June 1, 1991
Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivativesM Baba, E De Clercq, H Tanaka, et al.
Journal of Medicinal Chemistry|December 11, 1992
Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agentsH Tanaka, H Takashima, M Ubasawa, et al.
Pageof 4